CDK1 and neoplasm: Furthermore, increased doses of silymarin can decrease the levels of pCdc25c, Cdc25c, pCdc2, Cdc2, and Cyclin B1 proteins in TCC-SUP tumor cells, resulting in cell cycle arrest in the G2/M phase (Tan et al., 2002).